SCHEMBL7002677

SCHEMBL7002677

CN1Cc2cccnc2C(=O)c2c(Cl)cccc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
GABRA1 P14867 2/20 0.42
GABRG2 P18507 2/20 0.42
GABRB3 P28472 2/20 0.42
GABRA5 P31644 2/20 0.42
GABRA3 P34903 2/20 0.42
GABRA2 P47869 2/20 0.42
GABRA6 Q16445 2/20 0.42
GABRP O00591 1/20 0.37
GABRD O14764 1/20 0.37
GABRB1 P18505 1/20 0.37
GRM5 P41594 1/20 0.37
GABRB2 P47870 1/20 0.37
GABRA4 P48169 1/20 0.37
GABRE P78334 1/20 0.37
GABRG1 Q8N1C3 1/20 0.37
GABRG3 Q99928 1/20 0.37
GABRQ Q9UN88 1/20 0.37
TIPARP Q7Z3E1 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14415965 0.76 S100A4 (0.41) LMNASMN1; SMN2S100A4CDC25BNSD2
SCHEMBL7001329 0.75 LMNA (0.54) LMNASMN1; SMN2
SCHEMBL29431445 0.72 ADAM17 (0.48) LMNASMN1; SMN2S100A4CDC25BNSD2
SCHEMBL12573365 0.72 ADAM17 (0.48) LMNASMN1; SMN2S100A4CDC25BNSD2
SCHEMBL14996503 0.69 PARP1 (0.57) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL11732984 0.68 SMN1; SMN2 (0.49) LMNASMN1; SMN2TIPARP
SCHEMBL23085038 0.64 CHRM2 (0.46) LMNASMN1; SMN2
SCHEMBL30663589 0.64 LMNA (0.41) LMNASMN1; SMN2S100A4CDC25B
SCHEMBL754994 0.64 CES1 (0.50) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL26711480 0.63 LMNA (0.38) LMNASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1021448-B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY AS Ras-FPT INHIBITORS SCHERING CORP (US) 2003-05-02 EP disclosed
US-6130229-A Tricyclic compounds having activity as RAS-FPT inhibitors SCHERING CORPORATION (US) 2000-10-10 US disclosed